Aardvark Therapeutics Ownership | Who Owns Aardvark Therapeutics?

Aardvark Therapeutics Ownership Summary

Aardvark Therapeutics is owned by 38.24% institutional investors, 14.55% insiders, and 47.21% retail investors. Decheng capital is the largest institutional shareholder, holding 18.04% of AARD shares.

AARD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Aardvark Therapeutics	38.24%	14.55%	47.21%
Sector	Healthcare Stocks	232.12%	10.72%	-142.83%
Industry	Biotech Stocks	383.51%	10.54%	-294.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Decheng capital	3.92M	18.04%	$51.41M
Laurion capital management lp	1.05M	4.84%	$13.95M
Blackrock funding, inc. /de	784.43K	3.61%	$10.30M
Vanguard group	717.43K	3.30%	$9.42M
Adage capital partners gp	350.00K	1.61%	$4.65M
Silverarc capital management	303.94K	1.40%	$3.99M
Geode capital management	297.87K	1.37%	$3.91M
Schonfeld strategic advisors	253.75K	1.17%	$3.37M
Cresset asset management	146.78K	0.68%	$1.95M
Cantor fitzgerald, l. p.	96.68K	0.45%	$1.28M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Decheng capital	3.92M	6.92%	$51.41M
Silverarc capital management	303.94K	0.55%	$3.99M
Propel bio management	46.41K	0.52%	$609.11K
Laurion capital management lp	1.05M	0.24%	$13.95M
Gsa capital partners llp	35.92K	0.04%	$472.00K
Schonfeld strategic advisors	253.75K	0.02%	$3.37M
Cantor fitzgerald, l. p.	96.68K	0.01%	$1.28M
Adage capital partners gp	350.00K	0.01%	$4.65M
Cresset asset management	146.78K	0.01%	$1.95M
Bridgeway capital management	22.00K	0.01%	$292.38K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	784.43K	0.00%	474.96K
Adage capital partners gp	350.00K	0.01%	175.00K
Vanguard group	717.43K	0.00%	161.71K
Cresset asset management	146.78K	0.01%	146.78K
Geode capital management	297.87K	0.00%	103.83K

Top Sellers

Holder	Shares	% Assets	Change
Cormorant asset management, lp	-	-	-800.19K
Braidwell lp	-	-	-500.00K
Suvretta capital management	-	-	-312.50K
Bnp paribas arbitrage, snc	15.86K	0.00%	-40.69K
Balyasny asset management	-	-	-35.44K

New Positions

Holder	Shares	% Assets	Change	Value
Cresset asset management	146.78K	0.01%	146.78K	$1.95M
Propel bio management	46.41K	0.52%	46.41K	$609.11K
Nuveen	41.02K	0.00%	41.02K	$538.41K
Gsa capital partners llp	35.92K	0.04%	35.92K	$472.00K
Hrt financial lp	31.07K	0.00%	31.07K	$407.00K

Sold Out

Holder	Change
Srs capital advisors	-21.00
Pnc financial services group	-140.00
Strs ohio	-1.10K
Point72 asia (singapore) pte.	-1.28K
Walleye capital	-11.73K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	42	-12.50%	8,303,883	-12.23%	38	2.01%	31	-8.82%	5	-28.57%
Sep 30, 2025	47	34.29%	8,416,251	-5.60%	38	2.30%	33	10.00%	7	133.33%
Jun 30, 2025	35	29.63%	8,915,797	2.64%	41	0.95%	30	11.11%	3	-
Mar 31, 2025	27	-	8,686,452	-	65	-	27	-	-	-
Jun 30, 2015	1	-	1	-	-	-	1	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 11, 2025	Sun Nelson	Chief Financial Officer	Buy	$43.20K
Dec 11, 2025	Lee Tien-Li	Chief Executive Officer	Buy	$101.39K
Sep 15, 2025	Lee Tien-Li	Chief Executive Officer	Buy	$61.82K
Sep 15, 2025	Lee Tien-Li	Chief Executive Officer	Buy	$34.80K
Sep 11, 2025	Lee Tien-Li	Chief Executive Officer	Buy	$46.93K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q4	2	-
2025 Q3	6	-
2025 Q2	-	-
2007 Q3	1	-

AARD Ownership FAQ

Who Owns Aardvark Therapeutics?

Aardvark Therapeutics shareholders are primarily institutional investors at 38.24%, followed by 14.55% insiders and 47.21% retail investors. The average institutional ownership in Aardvark Therapeutics's industry, Biotech Stocks , is 383.51%, which Aardvark Therapeutics falls below.

Who owns the most shares of Aardvark Therapeutics?

Aardvark Therapeutics’s largest shareholders are Decheng capital (3.92M shares, 18.04%), Laurion capital management lp (1.05M shares, 4.84%), and Blackrock funding, inc. /de (784.43K shares, 3.61%). Together, they hold 26.49% of Aardvark Therapeutics’s total shares outstanding.

Does Blackrock own Aardvark Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aardvark Therapeutics.

Who is Aardvark Therapeutics’s biggest shareholder by percentage of total assets invested?

Decheng capital is Aardvark Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.92% of its assets in 3.92M Aardvark Therapeutics shares, valued at 51.41M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools